Tronox Holdings plc Stock 12‑Month Price Target Cut to $5.3, Implies 49% Upside

Tronox Holdings plc's average stock price target was reduced from $5.4 to $5.3 by 10 analysts, with a range of $3.5 to $8. This implies a 49% upside from the Nov. 4 closing price. The consensus rating remains 'Hold' with 2 Buys, 5 Holds, and 3 Sells.

Original reporting
Published Nov 5, 2026, 4:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 4:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tronox Holdings plc Stock 12‑Month Price Target Cut to $5.3, Implies 49% Upside — source image
Decision brief

The 30-second read

$TROXBearishLow
01

Why it matters

The target cut may trigger short‑term selling but long‑term fundamentals remain unchanged.

02

Market read

Analyst target revision provides modest trading signal for micro‑cap traders.

03

What to watch

Potential upside from upcoming contract wins or cost‑cut initiatives not reflected in the target.

Relevance 6/10Novelty 5/10Timing: today

Background

Tronox is a US‑listed chemical company; price‑target updates are routine analyst activity.

Company-level read

Ticker impact

$TROXBearishMedium confidence
Context

Analysts cut Tronox's average price target to $5.3 from $5.4, implying 49% upside.

Expected impact

likely downside pressure as the market prices in the lower target

Evidence & confidence

A lower consensus target reduces expected upside and may trigger sell‑offs.

Market effects

Minimal; reflects broader sentiment on chemical producers.

US market modestly affected; micro‑cap focus.

Low; limited to investors tracking Tronox.

Counterpoint

Some investors may view the 49% upside still present as a buying opportunity.

Key entities

  • Tronox Holdings plc

    US‑listed chemical producer (ticker TROX).

Related articles

$TROXMedAI 8/10

Tronox Reports Third Quarter 2026 Financial Results

Tronox Holdings plc (TROX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tronox Reports Third Quarter 2026 Financial Results Third quarter financial results in-line with prior guidance STAMFORD, Conn., November 4, 2026/PRNewswire/ — Tronox Holdings plc (NYSE:TROX) (“Tronox” or the “Company”), the world’s leading integrated manufacturer of

$TROXMedAI 8/10

Tronox (TROX) Q2 2026 Earnings Call Transcript

Tronox (TROX) reported Q2 2026 revenue of $868 million, up 19%, driven by higher TiO2 and zircon volumes. Net loss was $171 million, including a $103 million tax valuation allowance. Adjusted EBITDA fell 22% to $73 million. Free cash flow was $60 million. Q3 2026 adjusted EBITDA guidance is $95 million to $115 million.

$TROXMed

Tronox Q2 Earnings Call Highlights

Tronox (NYSE:TROX) said it is shifting from temporary TiO2 and zircon surcharges to more sustainable pricing. CFO John Srivisal cited pricing as the largest driver of expected Q3 earnings improvement, alongside outage and cost-program benefits. Tronox expects Q3 adjusted EBITDA of $95M to $115M, net debt of $3.0B, and India duty recommendations on Chinese TiO2.

$TROXMed

Tronox Reports Second Quarter 2026 Financial Results

Tronox Holdings plc (TROX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tronox Reports Second Quarter 2026 Financial Results STAMFORD, Conn., August 5, 2026/PRNewswire/ — Tronox Holdings plc (NYSE:TROX) (“Tronox” or the “Company”), the world’s leading integrated manufacturer of titanium dioxide (“TiO 2 ”) pigment, today reported its fina

$TROXMedAI 8/10

Tronox Reports Second Quarter 2026 Financial Results

Tronox Holdings plc (NYSE:TROX) reported Q2 2026 results for the quarter ended June 30, 2026. Revenue rose to $868 million, up 19% year over year. It posted a GAAP net loss of $171 million, or $1.07 per diluted share, and adjusted net loss of $82 million. Adjusted EBITDA was $73 million. The company expects full-year 2026 positive free cash flow and Q3 adjusted EBITDA of $95-$115 million.